These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 29921235

  • 1. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
    Zonneville J, Safina A, Truskinovsky AM, Arteaga CL, Bakin AV.
    BMC Cancer; 2018 Jun 19; 18(1):670. PubMed ID: 29921235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
    Shrivastav S, Bal A, Singh G, Joshi K.
    Clin Breast Cancer; 2016 Apr 19; 16(2):131-8. PubMed ID: 26452314
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
    Alex L, Tuleta I, Hernandez SC, Hanna A, Venugopal H, Astorkia M, Humeres C, Kubota A, Su K, Zheng D, Frangogiannis NG.
    Circulation; 2023 Sep 12; 148(11):882-898. PubMed ID: 37350296
    [Abstract] [Full Text] [Related]

  • 6. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression.
    Franco M, Roswall P, Cortez E, Hanahan D, Pietras K.
    Blood; 2011 Sep 08; 118(10):2906-17. PubMed ID: 21778339
    [Abstract] [Full Text] [Related]

  • 7. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
    Keskin D, Kim J, Cooke VG, Wu CC, Sugimoto H, Gu C, De Palma M, Kalluri R, LeBleu VS.
    Cell Rep; 2015 Feb 24; 10(7):1066-81. PubMed ID: 25704811
    [Abstract] [Full Text] [Related]

  • 8. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S, Zeng H, Xie XJ, Tao YK, He X, Roman RJ, Aschner JL, Chen JX.
    Oncotarget; 2016 Sep 13; 7(37):58848-58861. PubMed ID: 27613846
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
    Lin SL, Chang FC, Schrimpf C, Chen YT, Wu CF, Wu VC, Chiang WC, Kuhnert F, Kuo CJ, Chen YM, Wu KD, Tsai TJ, Duffield JS.
    Am J Pathol; 2011 Feb 13; 178(2):911-23. PubMed ID: 21281822
    [Abstract] [Full Text] [Related]

  • 11. Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.
    Sennino B, Falcón BL, McCauley D, Le T, McCauley T, Kurz JC, Haskell A, Epstein DM, McDonald DM.
    Cancer Res; 2007 Aug 01; 67(15):7358-67. PubMed ID: 17671206
    [Abstract] [Full Text] [Related]

  • 12. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
    Lugo R, Gabasa M, Andriani F, Puig M, Facchinetti F, Ramírez J, Gómez-Caro A, Pastorino U, Fuster G, Almendros I, Gascón P, Davalos A, Reguart N, Roz L, Alcaraz J.
    Oncotarget; 2016 Dec 13; 7(50):82324-82337. PubMed ID: 27384989
    [Abstract] [Full Text] [Related]

  • 13. Loss of TGFβ-Mediated Repression of Angiopoietin-2 in Pericytes Underlies Germinal Matrix Hemorrhage Pathogenesis.
    Dave JM, Chakraborty R, Agyemang A, Ntokou A, Saito J, Ballabh P, Martin KA, Greif DM.
    Stroke; 2024 Sep 13; 55(9):2340-2352. PubMed ID: 39129597
    [Abstract] [Full Text] [Related]

  • 14. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K, Le A, Weaver VM, Werb Z.
    Oncotarget; 2016 Dec 13; 7(50):82889-82901. PubMed ID: 27756881
    [Abstract] [Full Text] [Related]

  • 15. TGF-β-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion.
    Navarro R, Tapia-Galisteo A, Martín-García L, Tarín C, Corbacho C, Gómez-López G, Sánchez-Tirado E, Campuzano S, González-Cortés A, Yáñez-Sedeño P, Compte M, Álvarez-Vallina L, Sanz L.
    Mol Oncol; 2020 Oct 13; 14(10):2609-2628. PubMed ID: 32767843
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C, Li Y, Chen H, Zhang J, Zhang J, Qin T, Duan C, Chen X, Liu Y, Zhou X, Yang J.
    Cancer Lett; 2017 Aug 28; 402():131-141. PubMed ID: 28602979
    [Abstract] [Full Text] [Related]

  • 17. Pericyte ALK5/TIMP3 Axis Contributes to Endothelial Morphogenesis in the Developing Brain.
    Dave JM, Mirabella T, Weatherbee SD, Greif DM.
    Dev Cell; 2018 Mar 26; 44(6):665-678.e6. PubMed ID: 29456135
    [Abstract] [Full Text] [Related]

  • 18. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
    Safina A, Vandette E, Bakin AV.
    Oncogene; 2007 Apr 12; 26(17):2407-22. PubMed ID: 17072348
    [Abstract] [Full Text] [Related]

  • 19. Olfactomedin-like 3 promotes PDGF-dependent pericyte proliferation and migration during embryonic blood vessel formation.
    Imhof BA, Ballet R, Hammel P, Jemelin S, Garrido-Urbani S, Ikeya M, Matthes T, Miljkovic-Licina M.
    FASEB J; 2020 Nov 12; 34(11):15559-15576. PubMed ID: 32997357
    [Abstract] [Full Text] [Related]

  • 20. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E, Lauttia S, Zhang N, Tvorogov D, Kulmala J, Grenman R, Salven P, Elenius K.
    Microvasc Res; 2009 Dec 12; 78(3):278-85. PubMed ID: 19596357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.